Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Mar 15;101(6):1379–1388.

The 86-kD subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells.

G Teoh 1, M Urashima 1, E A Greenfield 1, K A Nguyen 1, J F Lee 1, D Chauhan 1, A Ogata 1, S P Treon 1, K C Anderson 1
PMCID: PMC508693  PMID: 9502780

Abstract

Previous studies have shown that triggering multiple myeloma (MM) cells via CD40 induces IL-6-mediated autocrine growth as well as increased expression of cell surface adhesion molecules including CD11a, CD11b, CD11c, and CD18. In this study, we generated the 5E2 mAb which targets an antigen that is induced upon CD40 ligand (CD40L) activation of MM cells. Immunofluorescence, immunoprecipitation, and protein sequencing studies identified the target antigen of 5E2 mAb as the 86-kD subunit of the Ku autoantigen. We demonstrate that increased cell surface expression of Ku on CD40L-treated cells is due to migration of Ku from the cytoplasm to the cell surface membrane. Moreover, cell surface Ku on CD40L-treated MM cells mediates homotypic adhesion of tumor cells, as well as heterotypic adhesion of tumor cells to bone marrow stromal cells and to human fibronectin; and 5E2 mAb abrogates IL-6 secretion triggered by tumor cell adherence to bone marrow stromal cells. These data suggest that CD40L treatment induces a shift of Ku from the cytoplasm to the cell surface, and are the first to show that Ku functions as an adhesion molecule. They further suggest that cell surface Ku may play a role in both autocrine and paracrine IL-6-mediated MM cell growth and survival.

Full Text

The Full Text of this article is available as a PDF (457.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aizawa S., Yaguchi M., Nakano M., Toyama K., Inokuchi S., Imai T., Yasuda M., Nabeshima R., Handa H. Hematopoietic supportive function of human bone marrow stromal cell lines established by a recombinant SV40-adenovirus vector. Exp Hematol. 1994 Jun;22(6):482–487. [PubMed] [Google Scholar]
  2. Allaway G. P., Vivino A. A., Kohn L. D., Notkins A. L., Prabhakar B. S. Characterization of the 70KDA component of the human Ku autoantigen expressed in insect cell nuclei using a recombinant baculovirus vector. Biochem Biophys Res Commun. 1990 Apr 30;168(2):747–755. doi: 10.1016/0006-291x(90)92385-d. [DOI] [PubMed] [Google Scholar]
  3. Anderson C. W., Lees-Miller S. P. The nuclear serine/threonine protein kinase DNA-PK. Crit Rev Eukaryot Gene Expr. 1992;2(4):283–314. [PubMed] [Google Scholar]
  4. Bakkus M. H., Van Riet I., Van Camp B., Thielemans K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Haematol. 1994 May;87(1):68–74. doi: 10.1111/j.1365-2141.1994.tb04872.x. [DOI] [PubMed] [Google Scholar]
  5. Barillé S., Collette M., Bataille R., Amiot M. Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. Blood. 1995 Oct 15;86(8):3151–3159. [PubMed] [Google Scholar]
  6. Boubnov N. V., Hall K. T., Wills Z., Lee S. E., He D. M., Benjamin D. M., Pulaski C. R., Band H., Reeves W., Hendrickson E. A. Complementation of the ionizing radiation sensitivity, DNA end binding, and V(D)J recombination defects of double-strand break repair mutants by the p86 Ku autoantigen. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):890–894. doi: 10.1073/pnas.92.3.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chan J. Y., Lerman M. I., Prabhakar B. S., Isozaki O., Santisteban P., Kuppers R. C., Oates E. L., Notkins A. L., Kohn L. D. Cloning and characterization of a cDNA that encodes a 70-kDa novel human thyroid autoantigen. J Biol Chem. 1989 Mar 5;264(7):3651–3654. [PubMed] [Google Scholar]
  8. Chauhan D., Kharbanda S., Ogata A., Urashima M., Teoh G., Robertson M., Kufe D. W., Anderson K. C. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood. 1997 Jan 1;89(1):227–234. [PubMed] [Google Scholar]
  9. Chauhan D., Kharbanda S., Uchiyama H., Urashima M., Fragoso R., Sen J., Kufe D. W., Anderson K. C. Identification of upstream signals regulating interleukin-6 gene expression during in vitro treatment of human B cells with pokeweed mitogen. Blood. 1994 Oct 1;84(7):2243–2252. [PubMed] [Google Scholar]
  10. Chauhan D., Pandey P., Ogata A., Teoh G., Treon S., Urashima M., Kharbanda S., Anderson K. C. Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism. Oncogene. 1997 Aug 14;15(7):837–843. doi: 10.1038/sj.onc.1201253. [DOI] [PubMed] [Google Scholar]
  11. Chauhan D., Uchiyama H., Akbarali Y., Urashima M., Yamamoto K., Libermann T. A., Anderson K. C. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. Blood. 1996 Feb 1;87(3):1104–1112. [PubMed] [Google Scholar]
  12. Dvir A., Peterson S. R., Knuth M. W., Lu H., Dynan W. S. Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11920–11924. doi: 10.1073/pnas.89.24.11920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Genersch E., Eckerskorn C., Lottspeich F., Herzog C., Kühn K., Pöschl E. Purification of the sequence-specific transcription factor CTCBF, involved in the control of human collagen IV genes: subunits with homology to Ku antigen. EMBO J. 1995 Feb 15;14(4):791–800. doi: 10.1002/j.1460-2075.1995.tb07057.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Giffin W., Torrance H., Rodda D. J., Préfontaine G. G., Pope L., Hache R. J. Sequence-specific DNA binding by Ku autoantigen and its effects on transcription. Nature. 1996 Mar 21;380(6571):265–268. doi: 10.1038/380265a0. [DOI] [PubMed] [Google Scholar]
  15. Gottlieb T. M., Jackson S. P. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell. 1993 Jan 15;72(1):131–142. doi: 10.1016/0092-8674(93)90057-w. [DOI] [PubMed] [Google Scholar]
  16. Grawunder U., Finnie N., Jackson S. P., Riwar B., Jessberger R. Expression of DNA-dependent protein kinase holoenzyme upon induction of lymphocyte differentiation and V(D)J recombination. Eur J Biochem. 1996 Nov 1;241(3):931–940. doi: 10.1111/j.1432-1033.1996.00931.x. [DOI] [PubMed] [Google Scholar]
  17. Hartley K. O., Gell D., Smith G. C., Zhang H., Divecha N., Connelly M. A., Admon A., Lees-Miller S. P., Anderson C. W., Jackson S. P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell. 1995 Sep 8;82(5):849–856. doi: 10.1016/0092-8674(95)90482-4. [DOI] [PubMed] [Google Scholar]
  18. Hoff C. M., Ghosh A. K., Prabhakar B. S., Jacob S. T. Enhancer 1 binding factor, a Ku-related protein, is a positive regulator of RNA polymerase I transcription initiation. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):762–766. doi: 10.1073/pnas.91.2.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hong T. J., Escribano J., Coca-Prados M. Isolation of cDNA clones encoding the 80-kd subunit protein of the human autoantigen Ku (p70/p80) by antisera raised against ciliary processes of human eye donors. Invest Ophthalmol Vis Sci. 1994 Nov;35(12):4023–4030. [PubMed] [Google Scholar]
  20. Kaczmarski W., Khan S. A. Lupus autoantigen Ku protein binds HIV-1 TAR RNA in vitro. Biochem Biophys Res Commun. 1993 Oct 29;196(2):935–942. doi: 10.1006/bbrc.1993.2339. [DOI] [PubMed] [Google Scholar]
  21. Kearney J. F., Radbruch A., Liesegang B., Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol. 1979 Oct;123(4):1548–1550. [PubMed] [Google Scholar]
  22. Klein B., Bataille R. Cytokine network in human multiple myeloma. Hematol Oncol Clin North Am. 1992 Apr;6(2):273–284. [PubMed] [Google Scholar]
  23. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  24. Le Romancer M., Cherifi Y., Reyl-Desmars F., Lewin M. J. Somatostatin specifically binds p86 subunit of the autoantigen Ku. C R Acad Sci III. 1993 Nov;316(11):1283–1285. [PubMed] [Google Scholar]
  25. Le Romancer M., Reyl-Desmars F., Cherifi Y., Pigeon C., Bottari S., Meyer O., Lewin M. J. The 86-kDa subunit of autoantigen Ku is a somatostatin receptor regulating protein phosphatase-2A activity. J Biol Chem. 1994 Jul 1;269(26):17464–17468. [PubMed] [Google Scholar]
  26. Lees-Miller S. P., Chen Y. R., Anderson C. W. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol Cell Biol. 1990 Dec;10(12):6472–6481. doi: 10.1128/mcb.10.12.6472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Liang F., Jasin M. Ku80-deficient cells exhibit excess degradation of extrachromosomal DNA. J Biol Chem. 1996 Jun 14;271(24):14405–14411. doi: 10.1074/jbc.271.24.14405. [DOI] [PubMed] [Google Scholar]
  28. Liang F., Romanienko P. J., Weaver D. T., Jeggo P. A., Jasin M. Chromosomal double-strand break repair in Ku80-deficient cells. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8929–8933. doi: 10.1073/pnas.93.17.8929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lokhorst H. M., Lamme T., de Smet M., Klein S., de Weger R. A., van Oers R., Bloem A. C. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood. 1994 Oct 1;84(7):2269–2277. [PubMed] [Google Scholar]
  30. Messier H., Fuller T., Mangal S., Brickner H., Igarashi S., Gaikwad J., Fotedar R., Fotedar A. p70 lupus autoantigen binds the enhancer of the T-cell receptor beta-chain gene. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2685–2689. doi: 10.1073/pnas.90.7.2685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mimori T., Akizuki M., Yamagata H., Inada S., Yoshida S., Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest. 1981 Sep;68(3):611–620. doi: 10.1172/JCI110295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mimori T., Ohosone Y., Hama N., Suwa A., Akizuki M., Homma M., Griffith A. J., Hardin J. A. Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1777–1781. doi: 10.1073/pnas.87.5.1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Niu H., Zhang J., Jacob S. T. E1BF/Ku interacts physically and functionally with the core promoter binding factor CPBF and promotes the basal transcription of rat and human ribosomal RNA genes. Gene Expr. 1995;4(3):111–124. [PMC free article] [PubMed] [Google Scholar]
  34. Nussenzweig A., Chen C., da Costa Soares V., Sanchez M., Sokol K., Nussenzweig M. C., Li G. C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 1996 Aug 8;382(6591):551–555. doi: 10.1038/382551a0. [DOI] [PubMed] [Google Scholar]
  35. Ogata A., Anderson K. C. Therapeutic strategies for inhibition of interleukin-6 mediated multiple myeloma cell growth. Leuk Res. 1996 Apr;20(4):303–307. doi: 10.1016/0145-2126(95)00085-2. [DOI] [PubMed] [Google Scholar]
  36. Ogata A., Chauhan D., Teoh G., Treon S. P., Urashima M., Schlossman R. L., Anderson K. C. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. J Immunol. 1997 Sep 1;159(5):2212–2221. [PubMed] [Google Scholar]
  37. Okumura K., Takagi S., Sakaguchi G., Naito K., Minoura-Tada N., Kobayashi H., Mimori T., Hinuma Y., Igarashi H. Autoantigen Ku protein is involved in DNA binding proteins which recognize the U5 repressive element of human T-cell leukemia virus type I long terminal repeat. FEBS Lett. 1994 Dec 12;356(1):94–100. doi: 10.1016/0014-5793(94)01243-1. [DOI] [PubMed] [Google Scholar]
  38. Ouyang H., Nussenzweig A., Kurimasa A., Soares V. C., Li X., Cordon-Cardo C., Li W. h., Cheong N., Nussenzweig M., Iliakis G. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J Exp Med. 1997 Sep 15;186(6):921–929. doi: 10.1084/jem.186.6.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pellat-Deceunynck C., Barillé S., Puthier D., Rapp M. J., Harousseau J. L., Bataille R., Amiot M. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res. 1995 Aug 15;55(16):3647–3653. [PubMed] [Google Scholar]
  40. Pilarski L. M., Belch A. R. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood. 1994 Feb 1;83(3):724–736. [PubMed] [Google Scholar]
  41. Porges A. J., Ng T., Reeves W. H. Antigenic determinants of the Ku (p70/p80) autoantigen are poorly conserved between species. J Immunol. 1990 Dec 15;145(12):4222–4228. [PubMed] [Google Scholar]
  42. Porter S. E., Greenwell P. W., Ritchie K. B., Petes T. D. The DNA-binding protein Hdf1p (a putative Ku homologue) is required for maintaining normal telomere length in Saccharomyces cerevisiae. Nucleic Acids Res. 1996 Feb 15;24(4):582–585. doi: 10.1093/nar/24.4.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Prabhakar B. S., Allaway G. P., Srinivasappa J., Notkins A. L. Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen. J Clin Invest. 1990 Oct;86(4):1301–1305. doi: 10.1172/JCI114838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Reeves W. H., Sthoeger Z. M. Molecular cloning of cDNA encoding the p70 (Ku) lupus autoantigen. J Biol Chem. 1989 Mar 25;264(9):5047–5052. [PubMed] [Google Scholar]
  45. Reeves W. H. Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J Exp Med. 1985 Jan 1;161(1):18–39. doi: 10.1084/jem.161.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rettig M. B., Ma H. J., Vescio R. A., Põld M., Schiller G., Belson D., Savage A., Nishikubo C., Wu C., Fraser J. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 1997 Jun 20;276(5320):1851–1854. doi: 10.1126/science.276.5320.1851. [DOI] [PubMed] [Google Scholar]
  47. Rothlein R., Springer T. A. The requirement for lymphocyte function-associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester. J Exp Med. 1986 May 1;163(5):1132–1149. doi: 10.1084/jem.163.5.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Smider V., Rathmell W. K., Lieber M. R., Chu G. Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science. 1994 Oct 14;266(5183):288–291. doi: 10.1126/science.7939667. [DOI] [PubMed] [Google Scholar]
  49. Teoh G., Anderson K. C. Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma. Hematol Oncol Clin North Am. 1997 Feb;11(1):27–42. doi: 10.1016/s0889-8588(05)70413-5. [DOI] [PubMed] [Google Scholar]
  50. Tong A. W., Zhang B. Q., Mues G., Solano M., Hanson T., Stone M. J. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro. Blood. 1994 Nov 1;84(9):3026–3033. [PubMed] [Google Scholar]
  51. Tuteja N., Tuteja R., Ochem A., Taneja P., Huang N. W., Simoncsits A., Susic S., Rahman K., Marusic L., Chen J. Human DNA helicase II: a novel DNA unwinding enzyme identified as the Ku autoantigen. EMBO J. 1994 Oct 17;13(20):4991–5001. doi: 10.1002/j.1460-2075.1994.tb06826.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Uchiyama H., Barut B. A., Chauhan D., Cannistra S. A., Anderson K. C. Characterization of adhesion molecules on human myeloma cell lines. Blood. 1992 Nov 1;80(9):2306–2314. [PubMed] [Google Scholar]
  53. Uchiyama H., Barut B. A., Mohrbacher A. F., Chauhan D., Anderson K. C. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood. 1993 Dec 15;82(12):3712–3720. [PubMed] [Google Scholar]
  54. Urashima M., Chauhan D., Hatziyanni M., Ogata A., Hollenbaugh D., Aruffo A., Anderson K. C. CD40 ligand triggers interleukin-6 mediated B cell differentiation. Leuk Res. 1996 Jun;20(6):507–515. doi: 10.1016/0145-2126(95)00098-4. [DOI] [PubMed] [Google Scholar]
  55. Urashima M., Chen B. P., Chen S., Pinkus G. S., Bronson R. T., Dedera D. A., Hoshi Y., Teoh G., Ogata A., Treon S. P. The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood. 1997 Jul 15;90(2):754–765. [PubMed] [Google Scholar]
  56. Urashima M., Ogata A., Chauhan D., Hatziyanni M., Vidriales M. B., Dedera D. A., Schlossman R. L., Anderson K. C. Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells. Blood. 1996 Mar 1;87(5):1928–1938. [PubMed] [Google Scholar]
  57. Westendorf J. J., Ahmann G. J., Armitage R. J., Spriggs M. K., Lust J. A., Greipp P. R., Katzmann J. A., Jelinek D. F. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol. 1994 Jan 1;152(1):117–128. [PubMed] [Google Scholar]
  58. Yaneva M., Arnett F. C. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol. 1989 Jun;76(3):366–372. [PMC free article] [PubMed] [Google Scholar]
  59. Yaneva M., Busch H. A 10S particle released from deoxyribonuclease-sensitive regions of HeLa cell nuclei contains the 86-kilodalton-70-kilodalton protein complex. Biochemistry. 1986 Sep 9;25(18):5057–5063. doi: 10.1021/bi00366a013. [DOI] [PubMed] [Google Scholar]
  60. Yaneva M., Ochs R., McRorie D. K., Zweig S., Busch H. Purification of an 86-70 kDa nuclear DNA-associated protein complex. Biochim Biophys Acta. 1985 Jul 26;841(1):22–29. doi: 10.1016/0304-4165(85)90270-3. [DOI] [PubMed] [Google Scholar]
  61. Zelazowski P., Max E. E., Kehry M. R., Snapper C. M. Regulation of Ku expression in normal murine B cells by stimuli that promote switch recombination. J Immunol. 1997 Sep 15;159(6):2559–2562. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES